摘要
Cancer cachexia is a multifactorial syndrome characterized by progressive weight loss and a disease process that nutritional support cannot reverse.Although progress has been made in preclinical research,there is still a long way to go in translating research findings into clinical practice.One of the main reasons for this is that existing preclinical models do not fully replicate the conditions seen in clinical patients.Therefore,it is important to understand the characteristics of existing preclinical models of cancer cachexia and pay close attention to the latest developments in preclinical models.The main models of cancer cachexia used in current research are allogeneic and xenograft models,genetically engineered mouse models,chemo-therapy drug-induced models,Chinese medicine spleen deficiency models,zebrafish and Drosophila models,and cellular models.This review aims to revisit and summarize the commonly used animal models of cancer cachexia by evaluating existing preclinical models,to provide tools and support for translational medicine research.
基金
supported by grants from the National Natural Science Foundation of China (No.82070912,82370899,and 81773326)
National Key Research and Development Program of China (2022YFF0710801).
